Patients with early rheumatoid arthritis (ERA) are likely to develop depression, with initial high disease activity correlating with the probability of depression and its persistence, according to a recent study. Moreover, such risk appears to be particularly modified in women with active disease and signifies an area for targeted focus and screening.
The risk of venous thromboembolism (VTE) in systemic sclerosis (SSc) is similar to that in the general population, according to a recent study. Risk factors for VTE include the presence of pulmonary arterial hypertension (PAH), peripheral arterial disease (PAD), Scl-70 and anticardiolipin antibodies.
Serum soluble (s)CD163 is associated with polymyositis (PM), classic dermatomyositis (DM) and clinical amyopathic dermatomyositis (CADM), especially in anti-MDA5 antibody-positive cases, but not specifically with rapidly progressive interstitial lung disease (RP-ILD) or ILD, according to a recent study.
It appears that ultrasound-detected synovitis (US+), especially when US is performed early in clinical remission, can help predict loss of remission in patients with rheumatoid arthritis (RA) in a real-life setting, suggests a recent study.
Following etanercept (ETN) withdrawal, a relapse occurs in a significant proportion of patients with juvenile idiopathic arthritis (JIA) who maintain clinically inactive disease (CID) for at least 6 months, a recent study has found.
Fungal microbiome, also called the mycobiome, appears to be highly variable in patients with well-characterized fungal diseases, a recent study has shown. Moreover, severe asthmatics have the highest fungal loads, along with those receiving steroid and antifungal therapy.